Latest Updates
-
Mahalakshmi Vrat 2026: What To Know About Today’s Udyapan, Rituals And Significance -
Jitiya Vrat 2026: Why Mothers Observe The Nirjala Fast, Paran Timings And Rituals Explained -
Drishyam: The Conclusion — Everything You Need To Remember Before Watching The New Film -
Jantar Mantar Protest On Gandhi Jayanti 2026: Why This Delhi Landmark Is A Hub For Public Demonstrations -
World Smile Day 2026: 5 Ways Smiling May Benefit Your Health And Support Everyday Wellbeing -
Lal Bahadur Shastri Jayanti 2026: 10 Quotes That Reflect His Ideas On Leadership, Peace And Nation-Building -
Gandhi Jayanti 2026: 10 Places In India Where You Can Experience Mahatma Gandhi’s Legacy -
International Day Of Non-Violence 2026: Why Was Gandhiji's Birthday Chosen For A Global Message Of Peace? -
Saptami Shraddha 2026: Who Should Perform It And What Does This Pitru Paksha Ritual Mean? -
Gandhi Jayanti 2026: 7 Sustainable Lifestyle Lessons We Can Still Learn From Gandhi
Biological E Ltd To Get mRNA Technology From WHO To Produce Covid-19 Vaccines
City-based vaccine maker Biological E. Limited on Monday said the company was selected as a recipient of mRNA technology to produce COVID-19 vaccines from the World Health Organisation.

A press release from BE Limited said the WHO's Advisory Committee on Vaccine Product Development (ACPDV) selected the firm after examining a number of proposals from India, as a recipient of mRNA (ribonucleic acid) technology from the global health body's technology transfer hub.
Mahima Datla, Managing Director, BE Ltd said: "BE has been investing in mRNA technologies since last year. This new technology will definitely strengthen our resolve to develop and manufacture more vaccines in future. This partnership with WHO will enhance our ability to develop next-generation mRNA vaccines that could be more suitable globally and expand the reach of vaccines availability worldwide.''
WHO and their partners will work with the Indian government and Biological E to develop a roadmap and put in place the necessary training and support for the vaccine maker to start producing mRNA vaccines as soon as possible.
Primarily set up to address the COVID-19 emergency, the WHO mRNA technology transfer hub has the potential to expand manufacturing capacity for other products as well, including treatments, and target other priorities.
mRNA vaccines use a messenger RNA created in a laboratory to teach the human cells how to produce a protein that in turn initiates an immune response inside the body against a particular disease. The immune response will fight the actual virus as it gets into the body.
At present, India has no COVID-19 vaccine made on an mRNA platform.
Last month, the Centra had given approval for Biological E's Corbevax to be administered to the 12-14 years age group across the country.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications
